https://scholars.lib.ntu.edu.tw/handle/123456789/586034
標題: | Major adverse cardiovascular and limb events in patients with diabetes treated with GLP-1 receptor agonists vs DPP-4 inhibitors | 作者: | Lin, Donna Shu-Han JEN-KUANG LEE WEN-JONE CHEN |
關鍵字: | Diabetes; Dipeptidyl peptidase-4 inhibitors; Glucagon-like peptide-1 receptor agonist; Major adverse cardiovascular events; Major adverse limb events | 公開日期: | 九月-2021 | 卷: | 64 | 期: | 9 | 來源出版物: | Diabetologia | 摘要: | The safety and efficacy of glucagon-like peptide-1 receptor agonists (GLP1RAs) and dipeptidyl peptidase-4 inhibitors (DPP4is) in major cardiovascular adverse events were previously examined in cardiovascular outcome trials. However, the effects of these drugs on adverse limb outcomes were poorly examined. This study aimed to determine the real-world outcomes of patients with diabetes mellitus receiving GLP1RAs as compared with those receiving DPP4is in terms of major adverse cardiovascular and limb events. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/586034 | ISSN: | 0012186X | DOI: | 10.1007/s00125-021-05497-1 | SDG/關鍵字: | 2,4 thiazolidinedione derivative; acetylsalicylic acid; alpha glucosidase inhibitor; anticoagulant agent; antidiabetic agent; beta adrenergic receptor blocking agent; calcium channel blocking agent; cilostazol; clopidogrel; cyclooxygenase 2 inhibitor; dig |
顯示於: | 醫學院附設醫院 (臺大醫院) |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。